股本结构
单位：万股
| 公告日期 | 2024-11-15 | 2024-11-12 | 2024-11-12 | 2024-08-06 | 2024-08-06 | 2024-05-07 |
|---|---|---|---|---|---|---|
| 证券总股本 | 14216.09 | 14212.06 | 14199.64 | 14178.48 | 14171.78 | 14001.77 |
| 普通股本 | 14216.09 | 14212.06 | 14199.64 | 14178.48 | 14171.78 | 14001.77 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-11-15 | 2024-11-08 | 2024-09-30 | 2024-08-02 | 2024-06-30 | 2024-05-03 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-11-15 | 14216.09 | 未披露 | 定期报告 | 2024-11-15 |
| 2024-11-12 | 14212.06 | 未披露 | 定期报告 | 2024-11-08 |
| 2024-11-12 | 14199.64 | 未披露 | 定期报告 | 2024-09-30 |
| 2024-08-06 | 14178.48 | 未披露 | 定期报告 | 2024-08-02 |
| 2024-08-06 | 14171.78 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-05-07 | 14001.77 | 未披露 | 定期报告 | 2024-05-03 |
| 2024-04-24 | 13983.06 | 未披露 | 定期报告 | 2024-04-03 |
| 2024-05-07 | 13968.20 | 未披露 | 定期报告 | 2024-03-31 |
| 2024-03-05 | 13956.92 | 未披露 | 定期报告 | 2024-02-29 |
| 2024-03-05 | 13942.83 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Exercise of equity-settled share-based payments
Share repurchase under NCIB
|
2023-12-31 |
| 2023-11-07 | 13914.88 | 未披露 | 定期报告 | 2023-11-03 |
| 2023-11-07 | 13913.13 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-08-09 | 13906.19 | 未披露 | 定期报告 | 2023-08-04 |
| 2023-08-09 | 13899.14 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-05-10 | 13869.66 | 未披露 | 定期报告 | 2023-05-05 |
| 2023-04-21 | 13862.91 | 未披露 | 定期报告 | 2023-04-03 |
| 2023-05-10 | 13862.75 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-20 | 13966.02 | 未披露 | 定期报告 | 2023-03-08 |
| 2023-03-08 | 13965.69 | 未披露 | 定期报告 | 2023-03-03 |
| 2023-03-08 | 13952.62 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of equity-settled share-based payments
Shares repurchased and cancelled
Effect of share repurchase liability
|
2022-12-31 |
| 2022-11-03 | 14130.89 | 未披露 | 定期报告 | 2022-10-28 |
| 2022-11-03 | 14130.12 | 未披露 | 定期报告 | 2022-09-30 |
| 2022-08-09 | 14129.01 | 未披露 | 定期报告 | 2022-08-05 |
| 2022-08-09 | 14128.71 | 未披露 | 定期报告 | 2022-06-30 |
| 2022-05-10 | 14139.18 | 未披露 | 定期报告 | 2022-05-06 |
| 2022-04-20 | 14168.79 | 未披露 | 定期报告 | 2022-04-14 |
| 2022-05-10 | 14182.32 | 未披露 | 定期报告 | 2022-03-31 |
| 2022-04-20 | 14301.32 | 未披露 | 定期报告 | 2022-03-04 |
| 2022-03-08 | 14299.41 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Share issuance
Exercise of stock options
|
2021-12-31 |
| 2021-11-09 | 14295.09 | 未披露 | 定期报告 | 2021-11-05 |
| 2021-10-08 | 14138.49 | 未披露 |
更多>>
1.Nuvei issued a total of 3,450,000 subordinate voting shares of the Company, including 450,000 subordinate voting shares following the exercise in full by the underwriters of their over-allotment option.
|
2021-10-08 |
| 2021-10-05 | 14093.49 | 未披露 | 定期报告 | 2021-10-06 |
From December 31,2022 to December 31,2023
Exercise of equity-settled share-based payments
Share repurchase under NCIB
From December 31, 2021 to December 31, 2022
Exercise of equity-settled share-based payments
Shares repurchased and cancelled
Effect of share repurchase liability
From January 1, 2021 to December 31, 2021
Share issuance
Exercise of stock options
1.Nuvei issued a total of 3,450,000 subordinate voting shares of the Company, including 450,000 subordinate voting shares following the exercise in full by the underwriters of their over-allotment option.